Initial assessment of outpatient visits to the cannabis abuse clinics
Tendances n° 50, OFDT, 4 p.
Within the framework of the government's action plan against illicit drugs, tobacco and alcohol (2004-2008), a prevention programme against cannabis use has been up. In February 2005, this programme included an awareness- raising media campaign and the setting up of specific outpatient clinics targeting people who have, or think they may have, an addiction to cannabis. These "riskassessment clinics" have been closely associated with the existing addiction treatment system.
The aim of these "clinics for young users" has been to offer young people an assessment of their consumption and a diagnosis of harmful use; to offer personalised information and advice to "high risk" users, to provide shortterm care to young people reporting harmful use without social or psychiatric complications; to accompany and provide counselling advice to young people if their situation warrants it; to offer support to parents having difficulties in coping with their children's consumption; to offer, if necessary, joint support for parents and children.
The objective of the present survey is to provide an insight into the population attending the clinics, by comparison with cannabis users in the general population. What specific treatment do these outpatient clinics offer to people with cannabis-related problems? How are they effective as a means to access care structures?
Download the PDF file (648 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2018 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.